20 stocks in focus on Monday: Lenskart, Natco Pharma, Power Grid, GHCL, Sigachi and others - The HinduBusinessLine
• Jubilant Pharmova Ltd announced that the USFDA has approved commercial batch manufacturing for the first product on Line 3, a new Isolator-based fill-and-finish line. • The approval applies to the Jubilant HollisterStier LLC (JHS) contract manufacturing facility located in Spokane, Washington, US. • This development is significant as it expands the production capabilities of Jubilant's subsidiary network, including Jubilant Pharma Holding Inc. and Jubilant Pharma Limited, Singapore.
thehindubusinessline.com
